Company / Gross Profit
Vanda Pharmaceuticals Inc. Gross Profit History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$42.2M
FY2019
5-year range
-
FY2016-FY2019
Trend
+9.2%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has increased for 3 consecutive years, from $24M in FY2016 to $42M in FY2019.
Based on SEC 10-K filings.
$42M in FY2019 with a 3-year CAGR of +20.1%.
Improved from $33M to $42M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +20.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Vanda Pharmaceuticals Inc.'s gross profit has grown for 3 consecutive years.
- 3-year CAGR of +20.1%, indicating consistent growth.
- In FY2019, gross profit increased 9.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $42.2M | +9.2% |
| FY2018 | $38.7M | +17.4% |
| FY2017 | $33.0M | +35.3% |
| FY2016 | $24.4M | +42.2% |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026